Application of ProTide Technology to Gemcitabine: A Successful Approach to Overcome the Key Cancer Resistance Mechanisms Leads to a New Agent (NUC-1031) in Clinical DevelopmentMagdalena Ślusarczyk, Christopher McGuigan, Monica Huerta Lopez et al.|Journal of Medicinal Chemistry|2014Cited by 151
Synthesis and biological evaluation of some cyclic phosphoramidate nucleoside derivativesAjit Kumar, Richard Walker, Jan Balzarini et al.|Journal of Medicinal Chemistry|1990Cited by 28